Measures · C18 in 2027 · Part C · HD2 Managing Chronic (Long Term) Conditions
Statin Therapy for Patients with Cardiovascular Disease
Chronic ConditionsHealth PlanMedication AdherenceSource: HEDIS
- What it measures
- This rating is based on the percent of plan members with heart disease who get the right type of cholesterol-lowering drugs. Health plans can help make sure their members are prescribed medications that are more effective for them.
- How it's calculated
- The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) (denominator) and were dispensed at least one high or moderate-intensity statin medication during the measurement year (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2025 – 12/31/2025
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Statin Therapy for Patients with Cardiovascular Disease (SPC)
- Exclusions
Show
Exclude members who meet any of the following criteria: • Pregnancy during the measurement year or year prior to the measurement year. • In vitro fertilization in the measurement year or year prior to the measurement year. • Dispensed at least one prescription for clomiphene (Table SPC-A) during the measurement year or the year prior to the measurement year. • ESRD or dialysis during the measurement year or the year prior to the measurement year. • Cirrhosis during the measurement year or the year prior to the measurement year. • Myalgia, myositis, myopathy, or rhabdomyolysis during the measurement year. • Members in hospice or using hospice services any time during the measurement year. • Members who died any time during the measurement year. • Members receiving palliative care any time during the measurement year. • Members 66 years of age and older as of December 31 of the measurement year who meet either of the following: – Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. – Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file to determine if a member had an LTI flag during the measurement year. • Members 66 years of age and older as of December 31 of the measurement year with frailty and advanced illness during the measurement year. Members must meet both of the following frailty and advanced illness criteria to be excluded: – At least two indications of frailty with different dates of service during the measurement year. – Any of the following during the measurement year or the year prior to the measurement year (count services that occur over both years): 1. At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits, virtual check-ins, nonacute inpatient encounters, or nonacute inpatient discharges on different dates of service, with an advanced illness diagnosis. Visit type need not be the same for the two visits. 2. At least one acute inpatient encounter with an advanced illness diagnosis. 3. At least one acute inpatient discharge with an advanced illness diagnosis on the discharge claim. 4. A dispensed dementia medication. The full set of exclusions is available in the NCQA HEDIS Measurement Year 2025 Technical Specifications Volume 2. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2025 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2025 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2026-2027) for contracts with 25% or more enrolled affected by 2025 disasters.
From the 2027 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2027 star distribution
Not rated: Plan too new to be measured (91); Not enough data available (76); Plan not required to report measure (54); Plan too small to be measured (52); No data available (3); Benefit not offered by plan (2)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 82 % | >= 82 % to < 86 % | >= 86 % to < 89 % | >= 89 % to < 93 % | >= 93 % |
| 2026 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 91 % | >= 91 % |
| 2025 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 92 % | >= 92 % |
| 2024 | MA | < 79 % | >= 79 % to < 84 % | >= 84 % to < 86 % | >= 86 % to < 90 % | >= 90 % |
| 2023 | MA | < 75 % | >= 75 % to < 81 % | >= 81 % to < 85 % | >= 85 % to < 89 % | >= 89 % |
| 2022 | MA | < 76 % | >= 76 % to < 81 % | >= 81 % to < 84 % | >= 84 % to < 89 % | >= 89 % |
| 2021 | MA | < 75% | >= 75% to < 79% | >= 79% to < 83% | >= 83% to < 87% | >= 87% |
| 2020 | MA | < 75% | ? 75% to < 79% | ? 79% to < 83% | ? 83% to < 87% | ? 87% |
| 2019 | MA | < 70% | ? 70% to < 76% | ? 76% to < 81% | ? 81% to < 85% | ? 85% |
Lowest-scoring contracts, 2027
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 55 | 1 | 0 | 34 | 0% |
| H4869 Gold Kidney Health Plan | Gold Kidney Health Plan | 6,263 | 74 | 1 | — | 15 | 0% |
| H6743 ATRIO Health Plans | ATRIO Health Plans | 21,042 | 76 | 1 | 0 | 13 | 0% |
| H3814 ATRIO Health Plans | ATRIO Health Plans | 1,997 | 76 | 1 | 0 | 13 | 0% |
| H9460 HealthSpring | Health Care Service Corporation | 1,325 | 77 | 1 | — | 12 | 1% |
| H7389 HealthSpring | Health Care Service Corporation | 0 | 77 | 1 | 0 | 12 | 1% |
| H8176 Molina Healthcare of South Carolina | Molina Healthcare, Inc. | 3,128 | 77 | 1 | −2 | 12 | 1% |
| H6158 Arkansas Blue Medicare | USAble Mutual Insurance Company | 4,842 | 79 | 1 | −1 | 10 | 2% |
| H4676 Troy Medicare | Troy Holdings, Inc. | 1,654 | 80 | 1 | −3 | 9 | 2% |
| H3204 Presbyterian Health Plan | Presbyterian Healthcare Services | 52,025 | 80 | 1 | −1 | 9 | 2% |
| H8649 Aetna Medicare | CVS Health Corporation | 1,503 | 81 | 1 | −3 | 8 | 2% |
| H7524 Excellus Health Plan Community Care LLC | Lifetime Healthcare, Inc. | 2,124 | 81 | 1 | — | 8 | 2% |
| H8133 Blue Cross and Blue Shield of Texas | Health Care Service Corporation | 2,507 | 81 | 1 | −4 | 8 | 2% |
| H2056 Aetna Medicare | CVS Health Corporation | 8,275 | 81 | 1 | −1 | 8 | 2% |
| H5439 Wellcare | Centene Corporation | 19,153 | 81 | 1 | 0 | 8 | 2% |
| H5434 Florida Blue | Guidewell Mutual Holding Corporation | 61,748 | 81 | 1 | 0 | 8 | 2% |
| H5580 Mercy Care Advantage | Mercy Care | 10,965 | 82 | 2 | 0 | 7 | 4% |
| H0439 HealthSpring | Health Care Service Corporation | 31,779 | 82 | 2 | 0 | 7 | 4% |
| H1914 Wellcare | Centene Corporation | 10,826 | 82 | 2 | 0 | 7 | 4% |
| H1666 Blue Cross and Blue Shield of NM, TX | Health Care Service Corporation | 15,741 | 82 | 2 | 0 | 7 | 4% |
| R0759 UnitedHealthcare | UnitedHealth Group, Inc. | 19,730 | 82 | 2 | 0 | 7 | 4% |
| H1248 Blue Cross and Blue Shield of Louisiana | Louisiana Health Service & Indemnity Company | 22,352 | 82 | 2 | 0 | 7 | 4% |
| H5590 Wellcare | Centene Corporation | 26,580 | 83 | 2 | 0 | 6 | 5% |
| R5941 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 13,077 | 83 | 2 | +1 | 6 | 5% |
| H4499 Sentara Medicare | Sentara Health Care (SHC) | 9,546 | 83 | 2 | — | 6 | 5% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C18 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2025 – 12/31/2025 | 1 | HEDIS |
| 2026 | C19 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2024 – 12/31/2024 | 1 | HEDIS |
| 2025 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2023 – 12/31/2023 | 1 | HEDIS |
| 2024 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2022 – 12/31/2022 | 1 | HEDIS |
| 2023 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2022 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C20 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C21 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C22 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2017 – 12/31/2017 | 1 | HEDIS |